Navigation Links
Commercial Insight: Antihormonal Cancer Therapies - Leading Brands Strive to Minimize Generic Sales Erosion
Date:11/8/2010

the aging population represents a large and growing patient base 32

Opportunity 2: generic sales erosion remains low in Japan 32

Opportunity 3: decrease in lag times for launch of new drugs could accelerate new launches 33

Threat 1: government-enforced biennial cuts continue to have a negative effect on market growth 33

Threat 2: healthcare proposal to change current pricing system will be of limited benefit to Japanese Pharma 34

Threat 3: encouraging decrease in lag times for launch of new drugs 34

Five major European markets (5EU) 36

Current and future market assessment 36

The antihormonals therapies market in the five European countries will show marginal growth 36

The antihormonal therapies market will grow from $2.6 billion in 2009 to $2.7 billion in 2019 in the five major European markets 38

Opportunities and threats 40

Opportunity 1: EU Cancer Task Force will improve the availability of information while generating funds for research 41

Opportunity 2: reorganization of the European Medicines Agency (EMA) expected to streamline EU regulatory process 41

Threat 1: new European drug price reductions are likely to affect pharma industry growth 41

Threat 2: higher generic uptake in less mature EU markets will impact branded sales revenues 42

Threat 3: EC inquiry into delays in generics market entry will have wide-ranging ramifications for the branded and generics industry 43

Threat 4: Spain's price cuts and reference groups are driving drug prices down 44

Threat 5: new low reimbursement rate created in France signals the growing pressure for cost-containment 44

Threat 6: NICE will remain a significant hurdle to commercialization of cancer drugs in the UK, despite relaxation of its cost-effectiveness criteria 45

Threat 7: Germany's new cost-effectiveness analysis system could add to the downward pressure on drug prices 46

Threat
'/>"/>

SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Pipeline Insight: Gastrointestinal Cancer Overview - Metastatic Gastrointestinal Cancers Represent a Significant Commercial Opportunity Due to a Lack of Approved Drugs
2. GSK and Amicus Therapeutics Enter Exclusive Worldwide Agreement to Develop and Commercialize Amigal™ for Fabry Disease
3. Amicus Therapeutics to Host Conference Call and Webcast to Discuss Exclusive Worldwide Agreement with GSK to Develop and Commercialize Amigal™ for Fabry Disease
4. High Unemployment Rates in North Carolina Will Continue to Dictate the Decrease of Commercial Health Plan Enrollment and the Increase of Medicaid Enrollment
5. Boehringer Ingelheim and MacroGenics Announce Global Alliance to Discover, Develop and Commercialize DART™-Based Antibody Therapeutics
6. Reportlinker Adds Commercializing Cancer Vaccines: A Decision Support Tool for Optimizing the Pipeline
7. Biocon and Pfizer Enter Into Global Commercialization Agreement
8. TaiGen Amends Global License Agreement with Warner Chilcott plc for Development and Commercialization of Nemonoxacin -- a New Generation Quinolone Antibiotic
9. OLIGOMERIX, Inc. Announces Board Changes: Vic Micati Appointed Chairman and Jack Pasini Appointed Company Director and Chief Commercial Officer
10. IRIDEX Announces Commercial Availability of New Adjustable & Intuitive EndoProbe® Device for Eye Surgery
11. Concentric Medical Announces Commercial Launch of Trevo™ in Europe
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/4/2015)... Aug. 04, 2015 ... the addition of the "MRI Systems Market ... Operational Efficiency, with Growth Driven by Developing Economies" ... Systems Market to 2020 - Focus on Patient ... Developing Economies" discusses the market, competitive landscape, and ...
(Date:8/4/2015)... Pharmaceuticals, Inc. (Nasdaq: ISIS ) today reported net ... three and six months ended June 30, 2015, respectively, ... $43.4 million for the same periods in 2014. Isis, ... more than $90 million of revenue Isis earned in ... Bayer to license  ISIS-FXI Rx .  Isis increased its ...
(Date:8/4/2015)... 4, 2015 Research and Markets ( ... Jain PharmaBiotech,s new report "Transdermal Drug ... to their offering. This ... an approach used to deliver drugs through ... alternative to oral,intravascular, subcutaneous and transmucosal routes. ...
Breaking Medicine Technology:Global MRI Systems Market Outlook to 2020 - Focus on Patient Comfort and Operational Efficiency, with Growth Driven by Developing Economies 2Isis Reports Financial Results And Highlights For Second Quarter 2015 2Isis Reports Financial Results And Highlights For Second Quarter 2015 3Isis Reports Financial Results And Highlights For Second Quarter 2015 4Isis Reports Financial Results And Highlights For Second Quarter 2015 5Isis Reports Financial Results And Highlights For Second Quarter 2015 6Isis Reports Financial Results And Highlights For Second Quarter 2015 7Isis Reports Financial Results And Highlights For Second Quarter 2015 8Isis Reports Financial Results And Highlights For Second Quarter 2015 9Isis Reports Financial Results And Highlights For Second Quarter 2015 10Isis Reports Financial Results And Highlights For Second Quarter 2015 11Isis Reports Financial Results And Highlights For Second Quarter 2015 12Isis Reports Financial Results And Highlights For Second Quarter 2015 13Isis Reports Financial Results And Highlights For Second Quarter 2015 14Isis Reports Financial Results And Highlights For Second Quarter 2015 15Isis Reports Financial Results And Highlights For Second Quarter 2015 16Transdermal Drug Delivery Report 2015-2024 - Technologies, Markets, and Companies Analysis 2
... announced that Brian Catlett has joined the company in ... will be a key member of Within3,s executive team ... the leading provider of online community solutions for life ... Within3 with more than 25 years of financial and ...
... YORK, May 26, 2011 Reportlinker.com announces that ... its catalogue: The Drug-Eluting Stent ... http://www.reportlinker.com/p0483600/The-Drug-Eluting-Stent-Market-Outlook-to-2016.html?utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_Delivery_Technology Introduction ... since the introduction of DES in 2003, but ...
Cached Medicine Technology:Within3 Adds Chief Financial Officer 2Reportlinker Adds The Drug-Eluting Stent Market Outlook to 2016 2Reportlinker Adds The Drug-Eluting Stent Market Outlook to 2016 3Reportlinker Adds The Drug-Eluting Stent Market Outlook to 2016 4Reportlinker Adds The Drug-Eluting Stent Market Outlook to 2016 5
(Date:8/4/2015)... , ... August 04, 2015 , ... An article ... financial incentives to be a viable method for encouraging people to lose weight. Specifically ... the future of their weight loss success, adding a financial incentive to the overall ...
(Date:8/4/2015)... ... 04, 2015 , ... Angelina Jolie is in it at age 39. “It” ... Dr. Angela DeRosa, DO, MBA, CPE aka “Dr. Hot Flash,” arguably the ... out of menopause. , Myth #1: Menopause only affects old ladies. – Menopause ...
(Date:8/4/2015)... ... August 04, 2015 , ... Worldwide Power Products acquires new ... its reach in Texas. Effective July 1st of this year, Worldwide Power Products ... With the North Texas acquisition, Worldwide Power Products (“WPP”) now services 1000 ...
(Date:8/4/2015)... ... 04, 2015 , ... Recent studies in the ... in binge drinking among certain populations and specific locations. Researchers, who ... examine trends and evidence to help facilitate health care treatment to meet current ...
(Date:8/4/2015)... ... 2015 , ... Members receiving care from a doctor who participates in a ... is nine percent lower -- than those members at traditional doctor practices, according to ... , “The promise of patient-centered, or value-based, care to deliver better quality care ...
Breaking Medicine News(10 mins):Health News:Article on Incentivizing Weight Loss Mirrors Similar Motivations Surrounding Weight Loss Surgery, Says Dr. Feiz & Associates 2Health News:"Dr. Hot Flash" Debunks the Top 5 Menopause Myths 2Health News:"Dr. Hot Flash" Debunks the Top 5 Menopause Myths 3Health News:North Texas Acquisition Press Release 2Health News:DARA Responds To International Trends in Binge Drinking 2Health News:DARA Responds To International Trends in Binge Drinking 3Health News:Horizon BCBSNJ: 2014 Results Show Patient-Centered Care Continues to Deliver on Promise of Better Quality Care at a Lower Cost 2Health News:Horizon BCBSNJ: 2014 Results Show Patient-Centered Care Continues to Deliver on Promise of Better Quality Care at a Lower Cost 3
... everyday life, emotional support, and cultural and recreational activities ... were the results of a dissertation from the Sahlgrenska ... amongst teenagers have increased markedly in recent years, especially ... as many as seven out of ten teenage girls ...
... pointers for better food choices for kids , , ... children dive into the pool, head to the park, and ... they may also leave nutrition behind; nutrition essential to fuel ... nutrition expert Chere Bork, a registered dietitian with more than ...
... the 400,000-strong seniors group RetireSafe saluted the Pharmaceutical ... commitment to support legislation to cut prescription drug ... into the Medicare Part D Prescription Drug Program ... "a huge gift to older Americans caught in ...
... suggests a direct link between smoking and brain damage will ... of Neurochemistry . Researchers, led by Debapriya Ghosh and Dr ... have found that a compound in tobacco provokes white blood ... leading to severe neurological damage. The research centers ...
... 23 Anglo Coal South Africa,a wholly owned subsidiary ... Coalition (GBC) on HIV/AIDS, Tuberculosis and Malaria for its,pioneering ... South,Africa. Anglo American is South Africa,s leading private sector ... The Business Excellence Award for ...
... 23 Helix BioPharma Corp. (TSX, FSE: HBP; OTCQX: HXBPF) ... on the OTCQX International Market under the ticker symbol HXBPF. ... about the OTCQX International Market at www.otcqx.com ... enhanced local access to the largest capital market in the ...
Cached Medicine News:Health News:How adolescent girls manage stress 2Health News:Summer is Here! Top Five Tips for Making Your Child's Summer Eating Habits Healthier 2Health News:New research discovers link between smoking and brain damage 2Health News:Anglo American's Coal Division in South Africa Wins Global Business Coalition Award for top International Workplace HIV and AIDS Programme 2Health News:Anglo American's Coal Division in South Africa Wins Global Business Coalition Award for top International Workplace HIV and AIDS Programme 3Health News:Helix Biopharma Corp. Begins Trading on the OTCQX International Market Listing as HXBPF 2Health News:Helix Biopharma Corp. Begins Trading on the OTCQX International Market Listing as HXBPF 3Health News:Helix Biopharma Corp. Begins Trading on the OTCQX International Market Listing as HXBPF 4
... device for the qualitative detection of drug or ... device can detect up to nine of the ... minutes and requires only a few drops of ... maximize convenience and ease of use. TOX/See features ...
... TOX/See™ is a 1-step, hand-held, point-of-care device ... metabolites in human urine. The TOX/See device ... commonly abused drugs in 3 to 8 minutes ... Each TOX/See cassette is individually packaged to maximize ...
... a 1-step, hand-held, point-of-care device for the qualitative ... urine. The TOX/See device can detect up ... in 3 to 8 minutes and requires only ... is individually packaged to maximize convenience and ease ...
... TOX/See™ is a 1-step, hand-held, point-of-care device for ... in human urine. The TOX/See device can ... abused drugs in 3 to 8 minutes and ... TOX/See cassette is individually packaged to maximize convenience ...
Medicine Products: